Category: by journal

Authors pull 4 papers from surgery journal for plagiarism

BMC SurgeryThe authors of four papers have pulled them for “significant overlap” with other publications, as well as borrowing “large portions of text” — in other words, plagiarism.

Two of the newly retracted papers published in BMC Surgery also listed co-authors who were “not involved in the study;” a similar note appears for an additional 2015 retraction that we’ve found for one of the authors.

That one author is listed on all of the newly retracted papers: Bruno Amato of the University Federico II of Naples, Italy.

Here’s the retraction notice for “Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis,” which has been cited five times since it was published in November, 2012, according to Thomson Reuters Web of Science: Continue reading Authors pull 4 papers from surgery journal for plagiarism

JAMA journals pull 3 papers by same authors for misconduct

JAMAJAMA and another journal in its network have retracted three 2005 papers about preventing hip fractures, after an admission of scientific misconduct. 

All papers are being retracted over concerns about data integrity, and “inappropriate assignment of authorship.” Four of the authors — all based in Japan — have co-authored all of the three newly retracted papers, and also share authorship of a previous retraction from 2015. 

The JAMA paper was tagged with an Expression of Concern last year, regarding the “conduct, integrity, and scientific validity” of the paper. 

Here’s the retraction notice for the JAMA paper, “Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke:” Continue reading JAMA journals pull 3 papers by same authors for misconduct

PLOS ONE republishes removed chronic fatigue syndrome data

PLOS OnePLOS ONE has republished data that were abruptly removed two weeks ago after the authors expressed concerns they did not have permission to release them.

The dataset — de-identified information from people with chronic fatigue syndrome — was removed May 18, noting it was “published in error.” But this week, the journal republished the dataset, saying the authors’ university had been consulted, and the dataset could be released.

This paper has drawn scrutiny for its similarities to a controversial “PACE” trial of chronic fatigue syndrome.

Here’s the second correction notice for “Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome,” released June 1:

Continue reading PLOS ONE republishes removed chronic fatigue syndrome data

Authors reused images in three papers, concludes journal probe

JBCBiologists are retracting three papers after the journal concluded they contain reused images, designed to represent different experiments. The authors stand by the conclusions, some of which they say have been “extensively validated.”

The Journal of Biological Chemistry used image analysis software to evaluate the images, first published at least a decade ago. Unfortunately, the raw data behind the problematic images were not available. The authors have also corrected a fourth paper in another journal, and wrote on PubPeer that they are working with journals to address concerns in three more.

The papers share two authors: Mireia Duñach at the Autonomous University of Barcelona, and Antonio García de Herreros at the Institut Hospital del Mar d’Investigacions Mèdiques. A representative of the Institut Hospital del Mar d’Investigacions Mèdiques told us it is looking into Garcia de Herreros’s work.

We’ll start with “β-Catenin N- and C-terminal tails modulate the coordinated binding of adherens junction proteins to β-catenin,” which has been cited 45 times since it was published in 2002, according to Thomson Reuters Web of Science. The retraction notice says:

Continue reading Authors reused images in three papers, concludes journal probe

Grad student who confessed to falsifying data barred from government funding

ori-logoNearly five months after a graduate student at the Albert Einstein College of Medicine spontaneously confessed to cooking data, the U.S. Office of Research Integrity (ORI) said today that she has agreed to exclude herself from receiving government funding for three years.

According to the ORI, Meredyth Forbes: Continue reading Grad student who confessed to falsifying data barred from government funding

JAMA takes all calls for retraction seriously — even from PETA

JAMAA leading medical journal is taking a second look at a recent high-profile paper about elephants’ lower risk of cancer, after receiving a call for retraction from a somewhat unusual corner: the animal rights group PETA.

This isn’t the first time the activist group has called for a retraction — last year, it nudged a journal to pull a paper that had been flagged for fraud by the U.S. Office of Research Integrity. Their latest target: A 2015 paper in JAMA, which PETA claims contains inaccurate information.

What’s more, the organization argues, Ringling Bros and Barnum & Bailey Circus — which partly funded the research — is using the findings as “justification for the continued use of abusive training techniques with elephants.” Yesterday, PETA sent a letter to the journal asking it to either retract the paper or issue an expression of concern, claiming: Continue reading JAMA takes all calls for retraction seriously — even from PETA

Author “committed serious mistakes,” finds Taipei investigation

Arteriosclerosis Thrombosis and Vascular BiologyAn investigation at Taipei Medical University found that an author made “serious mistakes” when preparing a manuscript.

The journal prompted the university to investigate the paper, which looks at the role of a protein in repairing arteries after an injury.

The retraction notice explains:

Continue reading Author “committed serious mistakes,” finds Taipei investigation

Fraudster’s colleague faked data, too

ori-logoA week after announcing that a researcher formerly at the University of Chicago had faked the results of more than 70 experiments, the U.S. Office of Research Integrity announced yesterday that one of his colleagues also falsified data.

According to the ORI, Karen D’Souza  Continue reading Fraudster’s colleague faked data, too

Lawsuit against publisher over retraction comes a step closer to reality

De GruyterAn author has begun the process of taking legal action against a publisher for retracting his paper.

As we reported last month, John Bishop, the CEO of an independent media company called Crocels, based in Pontypridd, Wales, argues that by taking down his paper, De Gruyter defamed him and breached a contract — their agreement to publish his paper. Now, Bishop has sent the publisher what’s known in the UK as a “letter of claim.”

In the letter, Bishop writes:

Continue reading Lawsuit against publisher over retraction comes a step closer to reality

What does “reproducibility” mean? New paper seeks to standardize the lexicon

Science Translational MedicineWhat is the difference between “reproducible” and “replicable”? And how does each relate to results that are “generalizable” and “robust”?

Researchers are using these terms interchangeably, creating confusion over what exactly is needed to confirm a scientific result, argues a new paper published today in Science Translational Medicine.

Here’s how the US National Science Foundation (NSF) defines “reproducibility,” according to the authors: Continue reading What does “reproducibility” mean? New paper seeks to standardize the lexicon